AeroLeads people directory · profile
Baruch Harris Email & Phone Number
Chief Operating Officer
at
Pretzel Therapeutics
LinkedIn matched
✓ Verified July 2026
3 data sources
Profile completeness 86%
Current company
Role
Chief Operating Officer
Location
Greater Boston, United States
Company size
Who is Baruch Harris? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Baruch Harris is listed as Chief Operating Officer at Pretzel Therapeutics, a with 47 employees, based in Greater Boston, United States. AeroLeads shows a matched LinkedIn profile for Baruch Harris.
Baruch Harris previously worked as Strategic Advisor at Ajinomoto Co., Inc. and Senior Advisor at Magnet Biomedicine. Baruch Harris holds Phd, Biochemistry & Molecular Biology from University Of California, San Francisco.
Company email context
Email format at Pretzel Therapeutics
This section adds company-level context without repeating Baruch Harris's masked contact details.
Pretzel Therapeutics
Review company-level records connected to Baruch Harris before choosing the right outreach path.
Profile bio
About Baruch Harris
Impactful biotechnology business leader with strong scientific acumen. Expertise across business development, investor relations, fundraising, R&D management, program leadership, and commercial and finance functions. Successful track record of de novo strategy development, excellence in execution, cross-functional leadership, and translation of complex scientific data to management, investors, and partners. In-depth experience delivering results for US, EU, and Japanese companies and markets. Ph.D. biochemistry, 12 peer-reviewed publications (6 first author).
Current workplace
Baruch Harris's current company
Company context helps verify the profile and gives searchers a useful next step.
Pretzel Therapeutics
18 roles
Baruch Harris work experience
A career timeline built from the work history available for this profile.
Strategic Advisor
Current
Nov 2024 - Present
Senior Advisor
Current
Jun 2023 - Present
Chief Operating Officer
CurrentPretzel's mission is to develop groundbreaking therapies leveraging a deep mechanistic understanding of mitochondrial biology. We are developing first-in-class therapeutics that can address mitochondrial dysfunction at its roots - promising medicines that address major unmet needs in a wide range of diseases, some of which lack meaningful treatment options today.As Chief Operating Officer, my scope of responsibility includes general operational management, fund raising & investor relations, business development, board management, corporate finance, and intellectual property, among other functions. I joined the company at the seed stage and was part of the core team that raised the series A.
Mar 2021 - Present
Senior Advisor
Apr 2021 - Apr 2022
Svp, Business Development
Apr 2020 - Apr 2021
Svp Business Development & Operations
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by illuminating the dark genome and decoding the repeatome within – the vast stretches of uncharted genetic material comprising repeat sequence motifs derived from the integration of viruses into the human genome throughout evolution.
Apr 2019 - Apr 2020
Independent Consultant
Biotechnology Business Consulting
Provide business development and operational support, strategy and execution for early to mid stage biotechnology companies.• Business strategy & operational execution• Negotiation & closing of licenses• Venture fundraising• Financial planning; budget creation & management• Program management• Technical & commercial diligence• Experience in diverse therapeutic areas & modalities
Jun 2016 - Mar 2022
Senior Advisor, Business Development
Yumanity Therapeutics
Oct 2020 - Oct 2021
Chief Operating Officer
• Brought on by investors and founders to lead company in turnaround situation; led company in partnership with CSO and Executive Chair, reporting to the Board• Closed $8.6M seed financing and $1.5M SBIR grant• Completed in-licensing of complementary preclinical program to Metera on favorable terms; progressed lead asset from pre-candidate selection to IND-enabling studies• Created company strategy, full program plan for 2 preclinical programs, budget & detailed business plan; led all aspects of financial and day-to-day business operational management• Built team of expert consultants, expanded Board, hired world-class CSO
Nov 2017 - Dec 2020
Business Development
Decibel signed a broad R&D collaboration with Regeneron in November 2017 which was later expanded and ultimately led to the company's acquisition in August 2023.
Feb 2017 - Jan 2018
Senior Director, Corporate Development And Program Executive
• Led investor relations efforts for FORUM and related corporate development activities• Led early-stage (Phase 1 & 2) program teams as well as safety task force for Phase 3 asset
Jan 2014 - May 2016
Venture Partner
F-Prime Capital Partners (fka Fidelity Biosciences) invests venture capital in private biopharmaceutical, medical technology, and healthcare IT and services companies.http://fprimecapital.com/
Jan 2013 - Dec 2013
Acting Ceo, Board Member
Entrega Inc.
Entrega, Inc. is a portfolio company of Enlight Biosciences / PureTech Health, developing a groundbreaking technology for oral delivery of peptides, proteins, and poorly bioavailable small molecules.
Jan 2012 - Dec 2012
Chief Business Officer, Enlight Biosciences
Chief Business Officer at Enlight Biosciences, a unique venture creation firm established by PureTech Ventures (now PureTech Health) in partnership with leading global pharmaceutical companies. Founded 3 life sciences companies (interim executive management, business development and day-to-day operations); managed relationships with Enlight’s 7 pharmaceutical partners and business operations for Enlight Biosciences itself.
Jul 2009 - Dec 2012
Head Of Business Strategy And Operations, Novartis Biologics
Led business planning and strategy; managed day-to-day operations, long-term operational planning; buy-side business development; competitive intelligence
Jul 2008 - Jul 2009
Senior Manager, Strategic Planning, Novartis Pharma
Buy-side M&A for Novartis Pharma Division; operational finance (organizational restructuring and ensuring bottom-line impact)
Jan 2007 - Jun 2008
Engagement Manager
Experience throughout the healthcare industry including pharmaceutical, biotech, payor / provider and private equity clients in US, EU and Japan; functional specialties including operations, strategy and commercial due diligence.
Oct 2003 - Dec 2006
3 education records
Baruch Harris education
Phd, Biochemistry & Molecular Biology
University Of California, San Francisco
Scb, Biophysics
Brown University
Education record
Hollis-Brookline High School
FAQ
Frequently asked questions about Baruch Harris
Quick answers generated from the profile data available on this page.
What company does Baruch Harris work for?
Baruch Harris works for Pretzel Therapeutics.
What is Baruch Harris's role at Pretzel Therapeutics?
Baruch Harris is listed as Chief Operating Officer at Pretzel Therapeutics.
Where is Baruch Harris based?
Baruch Harris is based in Greater Boston, United States while working with Pretzel Therapeutics.
What companies has Baruch Harris worked for?
Baruch Harris has worked for Pretzel Therapeutics, Ajinomoto Co., Inc., Magnet Biomedicine, Rome Therapeutics, and Biotechnology Business Consulting.
How can I contact Baruch Harris?
You can use AeroLeads to view verified contact signals for Baruch Harris at Pretzel Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Baruch Harris attend?
Baruch Harris holds Phd, Biochemistry & Molecular Biology from University Of California, San Francisco.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial